Stryker Crecimiento futuro

Future controles de criterios 2/6

Se prevé un crecimiento anual de los beneficios y los ingresos de Stryker de 12.7% y 6.9% por año respectivamente. Se prevé que el BPA crezca en un 12.7% al año. Se espera que la rentabilidad financiera sea de 21.2% en 3 años.

Información clave

10.5%

Tasa de crecimiento de los beneficios

10.6%

Tasa de crecimiento del BPA

Crecimiento de los beneficios de Medical Equipment	16.1%
Tasa de crecimiento de los ingresos	7.0%
Rentabilidad financiera futura	21.9%
Cobertura de analistas	Good
Última actualización	02 May 2024

Actualizaciones recientes sobre el crecimiento futuro

Stryker Corporation Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year

May 02

Stryker Corporation (NYSE:SYK) Analysts Are Pretty Bullish On The Stock After Recent Results

Feb 02

Recent updates

Stryker Corporation Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year

May 02

Stryker Corporation (NYSE:SYK) Analysts Are Pretty Bullish On The Stock After Recent Results

Feb 02

Stryker (NYSE:SYK) Seems To Use Debt Quite Sensibly

Jan 24

Here's Why We Think Stryker (NYSE:SYK) Might Deserve Your Attention Today

Jan 02

Stryker: Mako Shoulder And Spine Launches Are On The Way

Dec 31

Stryker's (NYSE:SYK) Shareholders Will Receive A Bigger Dividend Than Last Year

Dec 22

Stryker's (NYSE:SYK) Shareholders Will Receive A Bigger Dividend Than Last Year

Dec 08

Why Stryker Is An Awesome Healthcare Compounder

Nov 30

Is Now An Opportune Moment To Examine Stryker Corporation (NYSE:SYK)?

Nov 10

Investors Could Be Concerned With Stryker's (NYSE:SYK) Returns On Capital

Oct 19

Stryker: Don't Buy This Dividend Champion (Yet)

Oct 13

Estimating The Fair Value Of Stryker Corporation (NYSE:SYK)

Oct 08

Is Stryker (NYSE:SYK) A Risky Investment?

Sep 26

Stryker: Procedure Volume Recovery And Mako's Leading Robotic Technology

Aug 22

Some Investors May Be Worried About Stryker's (NYSE:SYK) Returns On Capital

Jul 18

Stryker Corporation's (NYSE:SYK) Intrinsic Value Is Potentially 18% Below Its Share Price

Jul 06

These 4 Measures Indicate That Stryker (NYSE:SYK) Is Using Debt Reasonably Well

Jun 17

Stryker: Good Prospects

Jun 14

With EPS Growth And More, Stryker (NYSE:SYK) Makes An Interesting Case

May 24

Should You Think About Buying Stryker Corporation (NYSE:SYK) Now?

May 01

Some Investors May Be Worried About Stryker's (NYSE:SYK) Returns On Capital

Apr 18

Calculating The Fair Value Of Stryker Corporation (NYSE:SYK)

Apr 06

Is Stryker (NYSE:SYK) Using Too Much Debt?

Feb 27

Stryker: Typically Excellent, Typically Expensive

Feb 16

Stryker Has A Slowing FCF Conversion And No Plans Of Share Buyback

Feb 07

If EPS Growth Is Important To You, Stryker (NYSE:SYK) Presents An Opportunity

Feb 02

Stryker Non-GAAP EPS of $3.00 beats by $0.16, revenue of $5.2B beats by $230M

Jan 31

Stryker initiated at sector weight by KeyBanc on limited upside potential

Jan 25

Stryker: Excellent Recent And Continuing Performance

Jan 09

Be Wary Of Stryker (NYSE:SYK) And Its Returns On Capital

Jan 08

At US$243, Is It Time To Put Stryker Corporation (NYSE:SYK) On Your Watch List?

Dec 26

Stryker's (NYSE:SYK) Upcoming Dividend Will Be Larger Than Last Year's

Dec 14

Calculating The Fair Value Of Stryker Corporation (NYSE:SYK)

Dec 12

Previsiones de crecimiento de beneficios e ingresos

NYSE:SYK - Estimaciones futuras de los analistas y datos financieros pasados (USD Millions)
Fecha	Ingresos	Beneficios	Flujo de caja libre	Flujo de caja operativo	Núm. de analistas medio
12/31/2026	25,809	4,985	4,566	5,510	19
12/31/2025	23,996	4,480	4,164	5,164	26
12/31/2024	22,302	3,907	3,446	4,394	24
3/31/2024	20,963	3,361	2,858	3,470	N/A
12/31/2023	20,498	3,165	3,136	3,711	N/A
9/30/2023	19,885	2,585	2,568	3,186	N/A
6/30/2023	19,455	2,709	2,417	3,025	N/A
3/31/2023	18,952	2,627	2,267	2,866	N/A
12/31/2022	18,449	2,358	2,036	2,624	N/A
9/30/2022	17,948	2,457	2,015	2,621	N/A
6/30/2022	17,629	2,079	2,067	2,665	N/A
3/31/2022	17,430	2,015	2,453	3,014	N/A
12/31/2021	17,108	1,994	2,738	3,263	N/A
9/30/2021	16,669	1,900	3,016	3,500	N/A
6/30/2021	16,246	2,083	2,973	3,396	N/A
3/31/2021	14,716	1,408	2,712	3,138	N/A
12/31/2020	14,351	1,599	2,790	3,277	N/A
9/30/2020	14,220	1,756	2,254	2,775	N/A
6/30/2020	14,070	1,601	1,960	2,575	N/A
3/31/2020	14,956	2,164	1,798	2,469	N/A
12/31/2019	14,884	2,083	1,542	2,191	N/A
9/30/2019	14,549	3,426	1,898	2,502	N/A
6/30/2019	14,204	3,550	1,910	2,491	N/A
3/31/2019	13,876	3,522	2,053	2,626	N/A
12/31/2018	13,601	3,553	2,038	2,610	N/A
9/30/2018	13,276	1,236	1,639	2,243	N/A
6/30/2018	13,040	1,080	1,098	1,704	N/A
3/31/2018	12,730	1,019	1,125	1,705	N/A
12/31/2017	12,444	1,020	N/A	1,559	N/A
9/30/2017	12,130	1,779	N/A	1,538	N/A
6/30/2017	11,957	1,700	N/A	1,961	N/A
3/31/2017	11,785	1,689	N/A	1,804	N/A
12/31/2016	11,325	1,647	N/A	1,915	N/A
9/30/2016	10,883	1,659	N/A	1,928	N/A
6/30/2016	10,470	1,605	N/A	917	N/A
3/31/2016	10,062	1,617	N/A	781	N/A
12/31/2015	9,946	1,439	N/A	981	N/A
9/30/2015	9,849	1,177	N/A	907	N/A
6/30/2015	9,818	933	N/A	1,940	N/A
3/31/2015	9,749	669	N/A	1,953	N/A
12/31/2014	9,675	515	N/A	1,782	N/A
9/30/2014	9,525	641	N/A	1,775	N/A
6/30/2014	9,287	687	N/A	1,873	N/A
3/31/2014	9,136	772	N/A	1,859	N/A
12/31/2013	9,021	1,006	N/A	1,886	N/A
9/30/2013	8,891	890	N/A	1,810	N/A
6/30/2013	8,792	1,140	N/A	1,757	N/A

Previsiones de crecimiento futuro de los analistas

Ingresos vs. Tasa de ahorro: El pronóstico de crecimiento de los beneficios (12.7% al año) de SYK es superior a la tasa de ahorro (2.3%).

Beneficios vs. Mercado: Se prevé que los beneficios (12.7% al año) de SYK crezcan menos que el mercado US (14.7% al año).

Beneficios de alto crecimiento: Se prevé que los beneficios de SYK crezcan, pero no significativamente.

Ingresos vs. Mercado: Se prevé que los ingresos (6.9% al año) de SYK crezcan más despacio que el mercado de US (8.1% al año).

Ingresos de alto crecimiento: Se prevé que los ingresos 6.9% al año) de SYK crezcan más despacio que 20% al año.

Previsiones de crecimiento de los beneficios por acción

Rentabilidad financiera futura

ROE futura: Se prevé que la rentabilidad financiera de SYK sea alta dentro de 3 años (21.2%)

Stryker Crecimiento futuro

Future controles de criterios 2/6

Información clave

Actualizaciones recientes sobre el crecimiento futuro

Stryker Corporation Provides Earnings Guidance for the Full Year 2024

Stryker Corporation Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year

Stryker Corporation (NYSE:SYK) Analysts Are Pretty Bullish On The Stock After Recent Results

Stryker Corporation Provides Earnings Guidance for the Year 2024

Stryker Corporation Provides Earnings Guidance for the Full Year 2023

Stryker Corporation Provides Earnings Guidance for the Year 2023

Recent updates

Stryker Corporation Provides Earnings Guidance for the Full Year 2024

Stryker Corporation Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year

First quarter 2024 earnings: EPS and revenues exceed analyst expectations

We Ran A Stock Scan For Earnings Growth And Stryker (NYSE:SYK) Passed With Ease

Stryker: A Great Company At An Expensive Price

Stryker Corporation to Report Q1, 2024 Results on Apr 30, 2024

Stryker's (NYSE:SYK) Dividend Will Be $0.80

Stryker Launches Gamma4 Hip Fracture Nailing System in Europe

Estimating The Fair Value Of Stryker Corporation (NYSE:SYK)

Upcoming dividend of US$0.80 per share

Stryker (NYSE:SYK) Hasn't Managed To Accelerate Its Returns

VP & Chief Accounting Officer notifies of intention to sell stock

At US$348, Is Stryker Corporation (NYSE:SYK) Worth Looking At Closely?

Stryker (NYSE:SYK) Has Announced A Dividend Of $0.80

Fourth quarter dividend of US$0.80 announced

New minor risk - Insider selling

Independent Director recently sold US$100m worth of stock

Independent Director notifies of intention to sell stock

Stryker: A Dividend Growth Powerhouse I'd Like To Own

Stryker Announces the Launch of Prophecy Footprint, an Expansion of the Prophecy Surgical Planning System, Offering Comprehensive Surgical Planning Across the Entire Foot

Stryker Corporation (NYSE:SYK) Analysts Are Pretty Bullish On The Stock After Recent Results

Full year 2023 earnings: EPS and revenues exceed analyst expectations

Stryker Corporation Provides Earnings Guidance for the Year 2024

Stryker (NYSE:SYK) Seems To Use Debt Quite Sensibly

VP & CFO exercised options and sold US$8.3m worth of stock

Here's Why We Think Stryker (NYSE:SYK) Might Deserve Your Attention Today

Insufficient new directors

Stryker: Mako Shoulder And Spine Launches Are On The Way

Stryker's (NYSE:SYK) Shareholders Will Receive A Bigger Dividend Than Last Year

Upcoming dividend of US$0.80 per share at 1.0% yield

Stryker Corporation (NYSE:SYK) executed a binding offer to acquire Serf from SAS Menix.

Stryker's (NYSE:SYK) Shareholders Will Receive A Bigger Dividend Than Last Year

Stryker Corporation, Annual General Meeting, May 09, 2024

Stryker Corporation Announces Dr. Srikant Datar Will Retire from Board of Directors

Stryker Corporation Declares Quarterly Dividend, Payable on January 31, 2024

VP & CFO exercised options and sold US$1.6m worth of stock

Why Stryker Is An Awesome Healthcare Compounder

Chairman notifies of intention to sell stock

Is Now An Opportune Moment To Examine Stryker Corporation (NYSE:SYK)?

Stryker Corporation Provides Earnings Guidance for the Full Year 2023

Third quarter 2023 earnings: EPS misses analyst expectations

Investors Could Be Concerned With Stryker's (NYSE:SYK) Returns On Capital

Stryker: Don't Buy This Dividend Champion (Yet)

Stryker to Showcase Q Guidance System with Spine Guidance Software

Estimating The Fair Value Of Stryker Corporation (NYSE:SYK)

Stryker Corporation to Report Q3, 2023 Results on Nov 02, 2023

Is Stryker (NYSE:SYK) A Risky Investment?

Upcoming dividend of US$0.75 per share at 1.0% yield

Stryker Launches PROstep® MIS Lapidus, a New Minimally Invasive Surgical Option for Treating Patients with Bunions

Stryker Corporation Releases Its Next-Generation of Advanced Surgical Cameras

Stryker’S Pangea Systems Receive Food & Drug Administration Clearance

Key Executive recently sold US$1.4m worth of stock

Stryker: Procedure Volume Recovery And Mako's Leading Robotic Technology

Stryker Corporation Provides Earnings Guidance for the Year 2023

Second quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Some Investors May Be Worried About Stryker's (NYSE:SYK) Returns On Capital

Stryker Corporation's (NYSE:SYK) Intrinsic Value Is Potentially 18% Below Its Share Price

Stryker Corporation to Report Q2, 2023 Results on Aug 03, 2023

Upcoming dividend of US$0.75 per share at 1.0% yield

These 4 Measures Indicate That Stryker (NYSE:SYK) Is Using Debt Reasonably Well

Stryker: Good Prospects

Independent Director recently sold US$139k worth of stock

Surgeons Successfully Complete First Surgical Cases Using Stryker’s Q Guidance System with Cranial Guidance Software

With EPS Growth And More, Stryker (NYSE:SYK) Makes An Interesting Case

Independent Director recently sold US$286k worth of stock

Independent Director notifies of intention to sell stock

Price target increased by 7.5% to US$310

Stryker Corporation Declares Quarter Dividend, Payable on July 31, 2023

First quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind